Film-Forming Gels for Topical Drug Delivery: A Systematic Review of the Effects of Formulation on Film Performance, Drug Release, and Skin Permeation
Abstract
Film-forming gels (FFGs) are increasingly recognized as a medium for topical drug delivery. However, existing evidence correlating specific formulation characteristics with drug delivery efficacy remains fragmented across many studies and is only partially organized. This systematic review aimed to consolidate these findings into a single framework and examine how important formulation variables affect three main outcome domains: film characteristics, drug release behavior, and skin permeation. A systematic search of PubMed and Scopus was conducted until October 2025, adhering to the PRISMA criteria. Studies were included if they examined topical FFG formulations and reported at least one of the predetermined outcomes. A total of 27 studies fulfilled the inclusion criteria, with solvent evaporation identified as the predominant method for FFG preparation. Across this body of research, the selection and relative ratio of polymers and plasticizers have consistently emerged as critical determinants influencing drying time (<15 min), mechanical strength, flexibility, and bioadhesive properties of the film on the skin. Most formulations released the drug slowly over approximately 8-48 hours. In studies that measured permeation, FFGs usually exhibited a higher flux and/or better drug retention in the skin than regular topical formulations. The film's ability to block the skin and the use of penetration enhancers in the matrix are thought to cause these effects. In summary, these…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Learning from First-Generation Qualitative Approaches in the IS Discipline: An Evolutionary View and Some Implications for Authors and Evaluators (PART 1/2)
- Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models
- Prosthesis: New Technological Opportunities and Innovative Biomedical Devices
- The history and future of neural modeling for cochlear implants
- Ryanodine receptors: waking up from refractoriness
- Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.